PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH
🇵🇬Papua New Guinea
- Country
- 🇵🇬Papua New Guinea
- Ownership
- -
- Established
- 1968-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.pngimr.org.pg/
A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women
Phase 4
- Conditions
- PregnancyInfections, PlasmodiaDrug KineticsClinical Efficacy
- Interventions
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 150
- Registration Number
- NCT02575755
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Madang, Madang Province, Papua New Guinea
Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
- First Posted Date
- 2015-02-18
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 150
- Registration Number
- NCT02364583
- Locations
- 🇵🇬
PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea
Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity
Phase 4
Completed
- Conditions
- Plasmodium Vivax InfectionPlasmodium Vivax Clinical EpisodePlasmodium Falciparum InfectionPlasmodium Falciparum Clinical Episode
- Interventions
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2014-05-21
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 524
- Registration Number
- NCT02143934
- Locations
- 🇵🇬
PNG Institute of Medical Research, Maprik, East Sepik Province, Papua New Guinea
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
Phase 3
- Conditions
- MeningitisOtitis MediaSepsisPneumoniaBacteraemia
- Interventions
- Biological: Prevenar 13 and Synflorix
- First Posted Date
- 2012-06-14
- Last Posted Date
- 2014-03-21
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 200
- Registration Number
- NCT01619462
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea
Artemether-Lumefantrine Clinical Effectiveness Study
Phase 4
Completed
- Conditions
- Parasitologically Confirmed; Malarial
- Interventions
- Drug: Artemether-lumefantrine combination
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2012-08-16
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 159
- Registration Number
- NCT01599000
- Locations
- 🇵🇬
Gurney Health Centre, Alotau, Milne Bay, Papua New Guinea
Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants
Not Applicable
Completed
- Conditions
- MalariaAnemia
- Interventions
- Drug: Amodiaquine/sulphadoxine-pyrimethamine, Artesunate/sulphadoxine-pyrimethamine or placebo
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 1100
- Registration Number
- NCT00285662
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea
Phase 2
Completed
- Conditions
- PneumoniaMeningitisOtitis Media
- Interventions
- Biological: Pneumococcal 7 valent conjugate vaccine (Prevenar®)
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 318
- Registration Number
- NCT00219401
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Goroka, EHP, Papua New Guinea
© Copyright 2025. All Rights Reserved by MedPath